Global GMP-grade mRNA Production Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11243459

Publication Date:

November 19, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

GMP-grade mRNA Production refers to the manufacture of messenger RNA (mRNA) molecules under Good Manufacturing Practices (GMP) guidelines. This ensures the mRNA is produced in a controlled, consistent, and highly regulated environment, meeting the stringent quality standards required for pharmaceutical or clinical applications, such as mRNA-based vaccines or therapeutics.
The global GMP-grade mRNA Production market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淕MP-grade mRNA Production Industry Forecast鈥� looks at past sales and reviews total world GMP-grade mRNA Production sales in 2022, providing a comprehensive analysis by region and market sector of projected GMP-grade mRNA Production sales for 2023 through 2029. With GMP-grade mRNA Production sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GMP-grade mRNA Production industry.
This Insight Report provides a comprehensive analysis of the global GMP-grade mRNA Production landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GMP-grade mRNA Production portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global GMP-grade mRNA Production market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GMP-grade mRNA Production and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GMP-grade mRNA Production.
United States market for GMP-grade mRNA Production is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for GMP-grade mRNA Production is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for GMP-grade mRNA Production is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key GMP-grade mRNA Production players cover Kaneka, Takara Bio, Vernal Biosciences, Creative Biogene, GenScript Biotech Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of GMP-grade mRNA Production market by product type, application, key players and key regions and countries.
Segmentation by Type:
Design and Synthesis
Production
Quality Assurance
Others
Segmentation by Application:
Vaccine Development
Drug Manufacturing
Technical Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Design and Synthesis
Production
Quality Assurance
Others
Segmentation by Application:
Vaccine Development
Drug Manufacturing
Technical Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Kaneka
Takara Bio
Vernal Biosciences
Creative Biogene
GenScript Biotech Corporation
RiboPro
Biomay
Lonza

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global GMP-grade mRNA Production Market Size 2019-2030
2.1.2 GMP-grade mRNA Production Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for GMP-grade mRNA Production by Country/Region, 2019, 2023 & 2030
2.2 GMP-grade mRNA Production Segment by Type
2.2.1 Design and Synthesis
2.2.2 Production
2.2.3 Quality Assurance
2.2.4 Others
2.3 GMP-grade mRNA Production Market Size by Type
2.3.1 GMP-grade mRNA Production Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global GMP-grade mRNA Production Market Size Market Share by Type (2019-2024)
2.4 GMP-grade mRNA Production Segment by Application
2.4.1 Vaccine Development
2.4.2 Drug Manufacturing
2.4.3 Technical Research
2.4.4 Others
2.5 GMP-grade mRNA Production Market Size by Application
2.5.1 GMP-grade mRNA Production Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global GMP-grade mRNA Production Market Size Market Share by Application (2019-2024)
3 GMP-grade mRNA Production Market Size by Player
3.1 GMP-grade mRNA Production Market Size Market Share by Player
3.1.1 Global GMP-grade mRNA Production Revenue by Player (2019-2024)
3.1.2 Global GMP-grade mRNA Production Revenue Market Share by Player (2019-2024)
3.2 Global GMP-grade mRNA Production Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GMP-grade mRNA Production by Region
4.1 GMP-grade mRNA Production Market Size by Region (2019-2024)
4.2 Global GMP-grade mRNA Production Annual Revenue by Country/Region (2019-2024)
4.3 Americas GMP-grade mRNA Production Market Size Growth (2019-2024)
4.4 APAC GMP-grade mRNA Production Market Size Growth (2019-2024)
4.5 Europe GMP-grade mRNA Production Market Size Growth (2019-2024)
4.6 Middle East & Africa GMP-grade mRNA Production Market Size Growth (2019-2024)
5 Americas
5.1 Americas GMP-grade mRNA Production Market Size by Country (2019-2024)
5.2 Americas GMP-grade mRNA Production Market Size by Type (2019-2024)
5.3 Americas GMP-grade mRNA Production Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GMP-grade mRNA Production Market Size by Region (2019-2024)
6.2 APAC GMP-grade mRNA Production Market Size by Type (2019-2024)
6.3 APAC GMP-grade mRNA Production Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe GMP-grade mRNA Production Market Size by Country (2019-2024)
7.2 Europe GMP-grade mRNA Production Market Size by Type (2019-2024)
7.3 Europe GMP-grade mRNA Production Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa GMP-grade mRNA Production by Region (2019-2024)
8.2 Middle East & Africa GMP-grade mRNA Production Market Size by Type (2019-2024)
8.3 Middle East & Africa GMP-grade mRNA Production Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global GMP-grade mRNA Production Market Forecast
10.1 Global GMP-grade mRNA Production Forecast by Region (2025-2030)
10.1.1 Global GMP-grade mRNA Production Forecast by Region (2025-2030)
10.1.2 Americas GMP-grade mRNA Production Forecast
10.1.3 APAC GMP-grade mRNA Production Forecast
10.1.4 Europe GMP-grade mRNA Production Forecast
10.1.5 Middle East & Africa GMP-grade mRNA Production Forecast
10.2 Americas GMP-grade mRNA Production Forecast by Country (2025-2030)
10.2.1 United States Market GMP-grade mRNA Production Forecast
10.2.2 Canada Market GMP-grade mRNA Production Forecast
10.2.3 Mexico Market GMP-grade mRNA Production Forecast
10.2.4 Brazil Market GMP-grade mRNA Production Forecast
10.3 APAC GMP-grade mRNA Production Forecast by Region (2025-2030)
10.3.1 China GMP-grade mRNA Production Market Forecast
10.3.2 Japan Market GMP-grade mRNA Production Forecast
10.3.3 Korea Market GMP-grade mRNA Production Forecast
10.3.4 Southeast Asia Market GMP-grade mRNA Production Forecast
10.3.5 India Market GMP-grade mRNA Production Forecast
10.3.6 Australia Market GMP-grade mRNA Production Forecast
10.4 Europe GMP-grade mRNA Production Forecast by Country (2025-2030)
10.4.1 Germany Market GMP-grade mRNA Production Forecast
10.4.2 France Market GMP-grade mRNA Production Forecast
10.4.3 UK Market GMP-grade mRNA Production Forecast
10.4.4 Italy Market GMP-grade mRNA Production Forecast
10.4.5 Russia Market GMP-grade mRNA Production Forecast
10.5 Middle East & Africa GMP-grade mRNA Production Forecast by Region (2025-2030)
10.5.1 Egypt Market GMP-grade mRNA Production Forecast
10.5.2 South Africa Market GMP-grade mRNA Production Forecast
10.5.3 Israel Market GMP-grade mRNA Production Forecast
10.5.4 Turkey Market GMP-grade mRNA Production Forecast
10.6 Global GMP-grade mRNA Production Forecast by Type (2025-2030)
10.7 Global GMP-grade mRNA Production Forecast by Application (2025-2030)
10.7.1 GCC Countries Market GMP-grade mRNA Production Forecast
11 Key Players Analysis
11.1 Kaneka
11.1.1 Kaneka Company Information
11.1.2 Kaneka GMP-grade mRNA Production Product Offered
11.1.3 Kaneka GMP-grade mRNA Production Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Kaneka Main Business Overview
11.1.5 Kaneka Latest Developments
11.2 Takara Bio
11.2.1 Takara Bio Company Information
11.2.2 Takara Bio GMP-grade mRNA Production Product Offered
11.2.3 Takara Bio GMP-grade mRNA Production Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Takara Bio Main Business Overview
11.2.5 Takara Bio Latest Developments
11.3 Vernal Biosciences
11.3.1 Vernal Biosciences Company Information
11.3.2 Vernal Biosciences GMP-grade mRNA Production Product Offered
11.3.3 Vernal Biosciences GMP-grade mRNA Production Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Vernal Biosciences Main Business Overview
11.3.5 Vernal Biosciences Latest Developments
11.4 Creative Biogene
11.4.1 Creative Biogene Company Information
11.4.2 Creative Biogene GMP-grade mRNA Production Product Offered
11.4.3 Creative Biogene GMP-grade mRNA Production Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Creative Biogene Main Business Overview
11.4.5 Creative Biogene Latest Developments
11.5 GenScript Biotech Corporation
11.5.1 GenScript Biotech Corporation Company Information
11.5.2 GenScript Biotech Corporation GMP-grade mRNA Production Product Offered
11.5.3 GenScript Biotech Corporation GMP-grade mRNA Production Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GenScript Biotech Corporation Main Business Overview
11.5.5 GenScript Biotech Corporation Latest Developments
11.6 RiboPro
11.6.1 RiboPro Company Information
11.6.2 RiboPro GMP-grade mRNA Production Product Offered
11.6.3 RiboPro GMP-grade mRNA Production Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 RiboPro Main Business Overview
11.6.5 RiboPro Latest Developments
11.7 Biomay
11.7.1 Biomay Company Information
11.7.2 Biomay GMP-grade mRNA Production Product Offered
11.7.3 Biomay GMP-grade mRNA Production Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biomay Main Business Overview
11.7.5 Biomay Latest Developments
11.8 Lonza
11.8.1 Lonza Company Information
11.8.2 Lonza GMP-grade mRNA Production Product Offered
11.8.3 Lonza GMP-grade mRNA Production Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lonza Main Business Overview
11.8.5 Lonza Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂